Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...

Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...

This week, Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about research underway to explore the use of stem cell therapy ...

TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under rigorous GMP conditions All 12 participants in Phase 1/2a were administered ...

Standard Parkinson’s disease treatment continues to be old drugs that get nerve cells to make dopamine, a brain chemical whose deficiency drives the central nervous system disorder. Bayer is taking a ...

L-leucine, an FDA-approved compound, exerts neuroprotective effects in Parkinson’s disease models. By reducing alpha-synuclein aggregation and restoring dopamine signaling, NALL targets multiple ...

Medications like levodopa and carbidopa may help you manage Parkinson's disease. You can try physical therapy to improve your balance, gait, and motor function. Deep brain stimulation is a surgical ...

For the first time, a stem cell replacement therapy has been found to be safe in a stage 1 clinical trial of patients living with Parkinson’s disease, drug developer BlueRock Therapeutics announced ...